TransMedics Group, Inc.【TMDX】 業績推移・財務諸表

(単位:千ドル) 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 4,676 5,666 7,205 6,057 7,530 3,391 7,091 7,627 7,053 8,171 5,370 15,880 20,521 25,683 41,554 52,465 66,430 96,850 114,305 108,761 143,537
売上成長率(%) - - - -
売上原価 2,103 2,333 2,989 - 2,670 1,482 2,053 - 2,242 2,582 1,597 3,776 6,171 7,568 12,788 15,724 25,768 36,888 45,044 47,916 55,309
売上総利益 2,573 3,333 4,216 3,741 4,860 1,909 5,038 4,828 4,811 5,589 3,773 12,104 14,350 18,115 28,766 36,741 40,662 59,962 69,261 60,845 88,228
売上総利益率(%)
研究開発費 3,882 4,787 4,939 - 6,225 3,903 4,155 - 4,532 6,295 5,163 7,534 6,714 6,808 5,871 8,291 11,132 11,380 13,858 14,266 17,160
販売管理費 4,653 6,251 6,519 - 6,652 5,867 5,493 - 6,786 9,162 10,335 13,939 17,381 16,851 24,984 29,356 30,653 36,161 42,895 42,656 43,625
営業費用 8,535 11,038 11,458 - 12,877 9,770 9,648 - 11,318 15,457 15,498 21,473 24,095 23,659 30,855 37,647 68,997 47,541 56,753 56,922 60,785
営業利益 -5,962 -7,705 -7,242 -8,694 -8,017 -7,861 -4,610 -5,896 -6,507 -9,868 -11,725 -9,369 -9,745 -5,544 -2,089 -906 -28,335 12,421 12,508 3,923 27,443
営業利益率 (%)
経常(税引前)利益 -6,885 -9,185 -8,270 - -8,842 -8,491 -5,082 - -7,913 -10,662 -12,953 -10,556 -11,501 -7,407 -2,625 -980 -26,929 12,393 12,153 4,245 26,676
経常(税引前)利益率(%) -147.24 -162.11 -114.78 - -117.42 -250.4 -71.67 - -112.19 -130.49 -241.21 -66.47 -56.05 -28.84 -6.32 -1.87 -40.54 12.8 10.63 3.9 18.58
法人税等合計 - - - - - - - - - - - - - - - - - - - - 994
実効税率(%) - - - - - - - - - - - - - - - - - - - -
純利益 -6,895 -9,195 -8,280 -9,177 -8,852 -8,497 -5,088 -6,311 -7,917 -10,668 -12,962 -10,562 -11,523 -7,426 -2,600 -1,001 -25,422 12,197 12,194 4,216 25,682
純利益率(%)
一株あたり利益 - - - - - - - - -0.29 -0.39 -0.47 -0.38 -0.41 -0.25 -0.08 -0.03 -0.78 0.37 0.37 0.13 0.76
希薄化後一株あたり利益 - - - - - - - - -0.29 -0.39 -0.47 -0.38 -0.41 -0.25 -0.08 -0.03 -0.78 0.35 0.35 0.12 0.7
一株あたり配当金 - - - - - - - - 0 - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - -